Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoproliferative Disorders × isatuximab × Clear all

Sponsor

Conditions

Multiple Myeloma 5 Purpura 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Nausea 1 Macroglossia 1 Lymphoma 1 Lymphadenopathy 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Immunoglobulin Light-chain Amyloidosis 1 Hepatomegaly 1 Gastrointestinal Hemorrhage 1 Diarrhea 1 Constipation 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

blinatumomab 4 Rituximab 3 ponatinib 2 Vorinostat 2 Vincristine 2 Prednisone 2 Ifosfamide 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Brentuximab Vedotin 2 Bortezomib 2 tetulomab tetraxetan lu-177 1 pegaspargase 1 ibritumomab tiuxetan 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 acalabrutinib 1 Methotrexate 1 Melphalan 1 Lutetium 1 KW-2478 1 Imatinib Mesylate 1 Hsp90 inhibitor KU757 1 Dexamethasone 1 Daunorubicin 1 Cytarabine 1 Carmustine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡